drugset / Trial / NCT03152552
A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure
RandomizedParallel-groupTriple-blindTreatment
Summary
This was a dose-finding study to evaluate the efficacy, safety and tolerability of 3 different doses of LIK066 compared to placebo or empagliflozin in T2DM patients with heart failure
Timeline
- Start
- 2017-07-25
- Primary completion
- 2018-06-06
- Completion
- 2018-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | — | Oral |
| Subject | licogliflozin | Small molecule | 2.5 mg | Oral |
| Subject | licogliflozin | Small molecule | 10 mg | Oral |
| Subject | licogliflozin | Small molecule | 50 mg | Oral |